A look at several clinically effective apps that treat mental illness directly with CBT and other therapy courses, as the FDA expedites the app approval process
Bill Bostock / Business Insider :
Context & Ripple Effects
Mental health apps spent 2020 split between two camps: consumer wellness products riding a demand spike — first-time downloads of the top 20 US mental wellness apps hit 4M in April alone, per Sensor Tower data — and platforms like Talkspace that route users to licensed human therapists after a $50M raise in 2019. Neither camp claimed to treat illness directly with structured therapy courses.
This piece covers the third camp: apps delivering actual CBT courses, now getting an expedited path through FDA review. That matters because the category's credibility problem is documented — gamification apps like SuperBetter faced open questions about effectiveness, while reporting on Better Help's data sharing practices showed wellness apps pinging third parties when a user opened the app or reported suicidal thoughts. FDA clearance gives developers a way to differentiate on evidence rather than engagement metrics.
First-order effects
- Developers of clinically validated CBT apps gain a regulatory moat over wellness-tier rivals like SuperBetter-style gamification apps, whose effectiveness questions remain unresolved.
- Patients seeking treatment rather than mood tracking get app-based therapy courses with an FDA-reviewed pathway, at a moment when April's 29% download surge shows demand outrunning therapist supply.
Second-order effects
- Human-in-the-loop platforms like Talkspace face pressure to show how their licensed-therapist model competes on price and access against software-only courses cleared by the FDA.
- Scrutiny of data practices sharpens: once an app makes clinical claims, the kind of third-party notifications documented at Better Help become a regulatory and reputational liability rather than a monetization detail.
Third-order effects
- If the expedited process holds, the market structurally bifurcates into FDA-cleared therapeutic apps and unregulated wellness apps, forcing payers, employers, and app stores to decide which tier they distribute — and regulators to extend oversight models built for devices to software treating illness directly.
The trend: Mental health software is splitting into a regulated clinical tier and an unregulated wellness tier, with the FDA's approval cadence deciding which apps can claim to treat illness rather than soothe it.